Maynard Um
-
-
-
-
-
-
-
Increasing unusual call option volume: OTLK EWJ AMPG LION MGNI TENB FSK CXW LASE
-
-
-
-
-
-
-
Outlook Therapeutics secures $18.4 million financing, extends convertible note
-
-
-
-
-
-
-
Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
-
-
-
-
-
-
-
Outlook Therapeutics plans BLA resubmission after FDA meeting
-
-
-
-
-
-
-
Outlook Therapeutics (OTLK) Appoints Bob Jahr as CEO
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Outlook Therapeutics Incs. (OTLK)
-
-
-
-
-
-
-
Outlook Therapeutics (OTLK) Reports Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
-
466,314 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


